Search Results

There are 26703 results for: content related to: Meta-analysis of epoetin beta and darbepoetin alfa treatment for chemotherapy-induced anemia and mortality: Individual patient data from J apanese randomized, placebo-controlled trials

  1. You have free access to this content
    Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis

    Intervention Review

    The Cochrane Library

    Suetonia C Palmer, Valeria Saglimbene, Dimitris Mavridis, Georgia Salanti, Jonathan C Craig, Marcello Tonelli, Natasha Wiebe and Giovanni FM Strippoli

    Published Online : 8 DEC 2014, DOI: 10.1002/14651858.CD010590.pub2

  2. Erythropoietin or darbepoetin for patients with cancer

    Intervention Review

    The Cochrane Library

    Thomy Tonia, Annette Mettler, Nadège Robert, Guido Schwarzer, Jerome Seidenfeld, Olaf Weingart, Chris Hyde, Andreas Engert and Julia Bohlius

    Published Online : 12 DEC 2012, DOI: 10.1002/14651858.CD003407.pub5

  3. You have free access to this content
    Darbepoetin for the anaemia of chronic kidney disease

    Intervention Review

    The Cochrane Library

    Suetonia C Palmer, Valeria Saglimbene, Jonathan C Craig, Sankar D Navaneethan and Giovanni FM Strippoli

    Published Online : 31 MAR 2014, DOI: 10.1002/14651858.CD009297.pub2

  4. Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data

    Intervention Review

    The Cochrane Library

    Julia Bohlius, Kurt Schmidlin, Corinne Brillant, Guido Schwarzer, Sven Trelle, Jerome Seidenfeld, Marcel Zwahlen, Mike J Clarke, Olaf Weingart, Sabine Kluge, Margaret Piper, Maryann Napoli, Dirk Rades, David Steensma, Benjamin Djulbegovic, Martin F Fey, Isabelle Ray-Coquard, Volker Moebus, Gillian Thomas, Michael Untch, Martin Schumacher, Matthias Egger and Andreas Engert

    Published Online : 8 JUL 2009, DOI: 10.1002/14651858.CD007303.pub2

  5. You have free access to this content
    Frequency of administration of erythropoiesis-stimulating agents for the anaemia of end-stage kidney disease in dialysis patients

    Intervention Review

    The Cochrane Library

    Deirdre Hahn, June D Cody and Elisabeth M Hodson

    Published Online : 28 MAY 2014, DOI: 10.1002/14651858.CD003895.pub3

  6. Evaluation of the US Oncology Network's Recommended Guidelines for Therapeutic Substitution with Darbepoetin alfa 200 μg Every 2 Weeks in Both Naïve Patients and Patients Switched from Epoetin alfa

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 3, March 2004, Pages: 313–323, William A. Thames, Sandra L. Smith, Andrew C. Scheifele, Bin Yao, Suzana A. Giffin and Julie L. Alley

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.24.4.313.33180

  7. Darbepoetin alfa: An Effective Treatment with Flexible and Simplified Dosing for Anemia in Patients with Cancer

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 27, Issue 3, March 2007, Pages: 434–446, Dr. James G. Stevenson and James J. Natale

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.27.3.434

  8. The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents

    Intervention Review

    The Cochrane Library

    Rahul Mhaskar, Hesborn Wao, Branko Miladinovic, Ambuj Kumar and Benjamin Djulbegovic

    Published Online : 4 FEB 2016, DOI: 10.1002/14651858.CD009624.pub2

  9. Exposure-Response Modeling of Darbepoetin Alfa in Anemic Patients With Chronic Kidney Disease Not Receiving Dialysis

    The Journal of Clinical Pharmacology

    Volume 50, Issue S9, September 2010, Pages: 75S–90S, Sameer Doshi, Andrew Chow and Juan José Pérez Ruixo

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010377201

  10. You have full text access to this Open Access content
    The Use of Darbepoetin to Stimulate Erythropoiesis in Anemia of Chronic Kidney Disease in Cats: 25 Cases

    Journal of Veterinary Internal Medicine

    Volume 26, Issue 2, March-April 2012, Pages: 363–369, S. Chalhoub, C.E. Langston and J. Farrelly

    Version of Record online : 1 FEB 2012, DOI: 10.1111/j.1939-1676.2011.00864.x

  11. You have full text access to this OnlineOpen article
    Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes

    British Journal of Haematology

    Volume 142, Issue 3, August 2008, Pages: 379–393, Janice Gabrilove, Ronald Paquette, Roger M. Lyons, Chaudhry Mushtaq, Mikkael A. Sekeres, Dianne Tomita and Lyndah Dreiling

    Version of Record online : 6 JUN 2008, DOI: 10.1111/j.1365-2141.2008.07181.x

  12. Darbepoetin alfa: A new erythropoietic drug for the treatment of renal anaemia

    Nephrology

    Volume 7, Issue 6, December 2002, Pages: 315–323, Amgen Anaemia Advisory Group

    Version of Record online : 9 OCT 2008, DOI: 10.1046/j.1440-1797.2002.00133.x

  13. Cost comparison of epoetin alpha, epoetin beta and darbepoetin alpha for cancer patients with anaemia in the clinical practice setting

    Journal of Clinical Pharmacy and Therapeutics

    Volume 31, Issue 5, October 2006, Pages: 503–512, B. Reichardt

    Version of Record online : 30 AUG 2006, DOI: 10.1111/j.1365-2710.2006.00757.x

  14. You have free access to this content
    Between subjects variability in haemoglobin and dose are not associated with the erythropoiesis-stimulating agent used to treat anaemia in dialysis: a meta-analysis

    British Journal of Clinical Pharmacology

    Volume 75, Issue 1, January 2013, Pages: 15–25, Juan José Pérez-Ruixo, Mercedes Cucala-Ramos, Ester García-Gonzalo, Beatriz Del Val Romero and Neus Valveny

    Version of Record online : 14 DEC 2012, DOI: 10.1111/j.1365-2125.2012.04383.x

  15. Erythropoietin-stimulating agents in the management of anemia of end-stage renal disease patients on regular hemodialysis: A prospective randomized comparative study from Qatar

    Hemodialysis International

    Volume 19, Issue 1, January 2015, Pages: 33–43, Fadwa Saqr Al-Ali, Mohamed El-Sayed Abdelfattah, Ashraf Ahmed Fawzy, Ahmed Farouk Hamdy and Aisha Elsayed Abdulla

    Version of Record online : 3 JUN 2014, DOI: 10.1111/hdi.12181

  16. Darbepoetin alfa: A new erythropoietic drug for the treatment of renal anaemia

    Nephrology

    Volume 7, Issue s2, May 2002, Pages: S173–S180, Amgen Anaemia Advisory Group

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1440-1797.2002.tb00530.x

  17. Darbepoetin alfa once monthly corrects anaemia in patients with chronic kidney disease not on dialysis

    Nephrology

    Volume 19, Issue 5, May 2014, Pages: 266–274, Simon D Roger, Elena Kolmakova, Maple Fung, Robert Malecki, José Vinhas, Frank Dellanna, Mark Thomas, Nick Manamley and Sándor Ferenczi

    Version of Record online : 21 APR 2014, DOI: 10.1111/nep.12214

  18. Impact of Long-Acting Growth Factors on Practice Dynamics and Patient Satisfaction

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 23, Issue 12P2, December 2003, Pages: 101S–109S, Dr. Roy A. Beveridge, Dr. Robert M. Rifkin, Dr. Ronald J. Moleski, Mr. Gary Milkovich, Dr. John F. Reitan, Mr. Thomas A. Paivanas and Mr. R. Jake Jacobs

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.23.16.101S.31971

  19. You have free access to this content
    Erythropoietin and iron therapy in patients with renal failure

    Transfusion Alternatives in Transfusion Medicine

    Volume 11, Issue 1, March 2010, Pages: 20–29, LUCIA DEL VECCHIO and FRANCESCO LOCATELLI

    Version of Record online : 16 OCT 2009, DOI: 10.1111/j.1778-428X.2009.01117.x

  20. C.E.R.A. once every 4 weeks in patients with chronic kidney disease not on dialysis: The ARCTOS extension study

    Hemodialysis International

    Volume 14, Issue 2, April 2010, Pages: 233–239, Michèle KESSLER, Alberto MARTÍNEZ-CASTELAO, Kostas C. SIAMOPOULOS, Giuseppe VILLA, Bruce SPINOWITZ, Frank C. DOUGHERTY and Ulrich BEYER

    Version of Record online : 3 NOV 2009, DOI: 10.1111/j.1542-4758.2009.00421.x